THE WASHINGTON TAX & PUBLIC POLICY GROUP

Lobbying for REGENERON PHARMACEUTICALS, INC. · Biotechnology company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New York · $30,000.00 income · posted Apr 1, 2026

Lobbying activity 1

Taxation/Internal Revenue Code

Issues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, and 174.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.